Last week, Dr Annemieke Witteveen presented her work on developing dynamic models for personalized prediction, monitoring and recommendations in oncology at a Biostatistics Seminar hosted by the Memorial Sloan Kettering (MSK) Cancer Center in New York.
MSK is one of the best cancer centres in the US. Dr Witteveen will be spending a month there as a visiting researcher in line with her Veni research. After this visit, she will spend an additional two months at Harvard. Dr Witteveen has been an assistant professor of eHealth Technology for Oncology in the Biomedical Signals and Systems research group since 2021. She is also one of UT’s Featured Scientists.